MedTrace Logo

DECAMP-1: Diagnosis and Surveillance of Indeterminate Pulmonary Nodules

NCT01785342 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 489

Last updated 2022-03-15

No results posted yet for this study

Summary

The goal is to improve the efficiency of the diagnostic follow-up of patients with indeterminate pulmonary nodules by determining whether biomarkers for lung cancer diagnosis that are measured in minimally invasive biospecimens are able to distinguish malignant from benign pulmonary nodules that are incidentally detected in high-risk smokers.

Conditions

Interventions

OTHER

Biosample and Imaging Collection

Collection of listed biosamples and CT imaging.

Sponsors & Collaborators

  • American College of Radiology Imaging Network

    collaborator NETWORK

  • National Cancer Institute (NCI)

    collaborator NIH

  • Boston University

    lead OTHER

Principal Investigators

  • Ehab Billatos, MD · Boston University

  • Deni Aberle, MD · University of California, Los Angeles

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01785342 on ClinicalTrials.gov